ABSTRACT
The protease of HIV plays a critical role in the maturation of the infectious particles of the virus. The enzyme has therefore been extensively studied with the objective of developing therapeutics that inhibit viral proliferation. We have produced monoclonal antibodies specific for the HIV-1 protease, and selected those that inhibit enzyme function for use as probes to study the enzyme's activity and as an eventual aid for the development of potential inhibitors targeted to regions other than the active site. We have characterized two such mAbs, F11.2.32 and 1696, which have inhibition constants in the low nanomolar range and which recognize epitopes from different regions of the protease. The crystal structures of the two antibodies, both in the free state as well as complexes with peptide fragments corresponding to their respective epitopes, have been solved. The structural analyses, taken together with other functional data on the antibodies, suggest mechanisms of protease inhibition by these antibodies.
Subject(s)
Antibodies, Monoclonal/pharmacology , HIV Protease Inhibitors/immunology , HIV Protease/immunology , Animals , Antibodies, Monoclonal/chemistry , HIV Antibodies/chemistry , HIV Antibodies/pharmacology , HIV Protease/chemistry , HIV Protease Inhibitors/chemistry , HIV Protease Inhibitors/pharmacology , HIV-1/enzymology , HIV-1/immunology , In Vitro Techniques , Mice , Models, Molecular , Molecular Structure , Protein ConformationABSTRACT
The monoclonal antibody 1696, directed against the HIV-1 protease, displays strong inhibitory effects toward the catalytic activity of the enzyme of both the HIV-1 and HIV-2 isolates. This antibody cross-reacts with peptides that include the N-terminus of the enzyme, a region that is well conserved in sequence among different viral strains and which, furthermore, is crucial for homodimerization to the active enzymatic form. This observation, as well as antigen-binding studies in the presence of an active site inhibitor, suggest that 1696 inhibits the HIV protease by destabilizing its active homodimeric form. To characterize further how the antibody 1696 inhibits the HIV-1 and HIV-2 proteases, we have solved the crystal structure of its Fab fragment by molecular replacement and refined it at 3.0 A resolution. The antigen binding site has a deep cavity at its center, which is lined mainly by acidic and hydrophobic residues, and is large enough to accommodate several antigen residues. The structure of the Fab 1696 could form a starting basis for the design of alternative HIV protease-inhibiting molecules of broad specificity.
Subject(s)
Antibodies, Monoclonal/chemistry , Antibodies, Viral/chemistry , HIV Protease Inhibitors/chemistry , HIV Protease/chemistry , HIV-1/chemistry , HIV-2/chemistry , Amino Acid Sequence , Animals , Base Sequence , Epitope Mapping , Epitopes , Escherichia coli/metabolism , HIV Protease/immunology , HIV Protease/metabolism , HIV-1/immunology , Immunoglobulin Fab Fragments/chemistry , Mice , Mice, Inbred BALB C , Models, Molecular , Molecular Sequence Data , Protein Denaturation , X-Ray DiffractionSubject(s)
Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/pharmacology , HIV Antibodies/chemistry , HIV Antibodies/pharmacology , HIV Protease Inhibitors/chemistry , HIV Protease Inhibitors/pharmacology , HIV Protease/immunology , HIV-1/enzymology , HIV-1/immunology , Amino Acid Sequence , Animals , Antigen-Antibody Complex/chemistry , Biophysical Phenomena , Biophysics , Crystallography, X-Ray , Epitopes/chemistry , Epitopes/genetics , HIV Antigens/chemistry , HIV Antigens/genetics , HIV Protease/genetics , HIV-1/genetics , MiceSubject(s)
HIV Antibodies/chemistry , HIV Protease/chemistry , HIV Protease/immunology , HIV-1/enzymology , HIV-1/immunology , Animals , Antibodies, Monoclonal/chemistry , Antigen-Antibody Complex/chemistry , Biophysical Phenomena , Biophysics , Crystallization , Crystallography, X-Ray , HIV Antigens/chemistry , HIV Protease Inhibitors/chemistry , HIV Protease Inhibitors/immunology , Macromolecular Substances , Mice , Protein ConformationABSTRACT
F11.2.32, a monoclonal antibody raised against HIV-1 protease (Kd = 5 nM), which inhibits proteolytic activity of the enzyme (K(inh) = 35(+/-3)nM), has been studied by crystallographic methods. The three-dimensional structure of the complex between the Fab fragment and a synthetic peptide, spanning residues 36 to 46 of the protease, has been determined at 2.2 A resolution, and that of the Fab in the free state has been determined at 2.6 A resolution. The refined model of the complex reveals ten well-ordered residues of the peptide (P36 to P45) bound in a hydrophobic cavity at the centre of the antigen-binding site. The peptide adopts a beta hairpin-like structure in which residues P38 to P42 form a type II beta-turn conformation. An intermolecular antiparallel beta-sheet is formed between the peptide and the CDR3-H loop of the antibody; additional polar interactions occur between main-chain atoms of the peptide and hydroxyl groups from tyrosine residues protruding from CDR1-L and CDR3-H. Three water molecules, located at the antigen-antibody interface, mediate polar interactions between the peptide and the most buried hypervariable loops, CDR3-L and CDR1-H. A comparison between the free and complexed Fab fragments shows that significant conformational changes occur in the long hypervariable regions, CDR1-L and CDR3-H, upon binding the peptide. The conformation of the bound peptide, which shows no overall structural similarity to the corresponding segment in HIV-1 protease, suggests that F11.2.32 might inhibit proteolysis by distorting the native structure of the enzyme.
Subject(s)
Antibodies, Monoclonal/chemistry , HIV Protease Inhibitors/chemistry , Immunoglobulin Fab Fragments/chemistry , Amino Acid Sequence , Antibodies, Monoclonal/genetics , Base Sequence , Binding Sites , Cloning, Molecular , Computer Simulation , Cross Reactions , Crystallography, X-Ray , HIV Protease , Hybridomas , Immunoglobulin Fab Fragments/genetics , Models, Molecular , Molecular Sequence Data , Sequence Analysis, DNAABSTRACT
F11.2.32, a monoclonal antibody directed against the HIV-1 protease, displays strong inhibitory effects toward the catalytic activity of the enzyme. The antibody cross-reacts with peptides 36-46 and 36-57 from the protease. Crystals of the Fab have been obtained both in the free state and as complexes formed with the protease peptide fragments, 36-46 and 36-57. Diffraction data have been collected for the free and complexed forms of Fab F11.2.32 and preliminary models for the crystal structures were obtained by molecular replacement.
